2021
DOI: 10.1016/j.jgg.2021.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Multiomics metabolic and epigenetics regulatory network in cancer: A systems biology perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 97 publications
0
2
0
Order By: Relevance
“…One common theme in the epigenetics field over the past 20 years was research focused on genome sequencing methods, techniques, and data science (Figure 3). We identified substantial interest in analysis techniques associated with interpreting epigenetic data, such as the use of enrichment networks in conjunction with epigenetic data (Wang et al, 2021). The development of these methodologies and associated analysis techniques is critically important for how we assess the epigenomes of wild-living populations and individuals.…”
Section: What Is the Future Of Eco-epi?mentioning
confidence: 99%
“…One common theme in the epigenetics field over the past 20 years was research focused on genome sequencing methods, techniques, and data science (Figure 3). We identified substantial interest in analysis techniques associated with interpreting epigenetic data, such as the use of enrichment networks in conjunction with epigenetic data (Wang et al, 2021). The development of these methodologies and associated analysis techniques is critically important for how we assess the epigenomes of wild-living populations and individuals.…”
Section: What Is the Future Of Eco-epi?mentioning
confidence: 99%
“…Most studies on circRNAs in cancer have not addressed these issues but rather focused on a specific cancer type and para-cancer tissues. They failed to study circRNAs from a pan-cancer view, although the circRNAs related to the common dysregulations in oncogenesis may reveal the principles of circRNA dysregulations in cancer and have higher robustness as therapeutic targets and cancer biomarkers (17). It was ignored that circRNAs are expressed by diverse normal tissues in vivo and secreted into plasma exosomes.…”
Section: Introductionmentioning
confidence: 99%